Quick Answer
LakeShore Biopharma Co., Ltd. reported Shares Outstanding of 20.77 million shares for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 20.77M | +9.2% |
| 2024 | 19.02M | -79.6% |
| 2023 | 93.06M | +50.5% |
| 2022 | 61.83M | — |
- LakeShore Biopharma Co., Ltd. showed an increase of +9.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, LakeShore Biopharma Co., Ltd.’s shares outstanding has declined by 66.4% (from 61.83 million shares to 20.77 million shares).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: